Study investigating the role of skeletal muscle mass estimation in metastatic spinal cord compression

European Spine Journal

Volumn 24, Issue 10, 2015, Pages 2150-2155

  Gakhar, H ^a   Dhillon, A ^a   Blackwell, J ^a   Hussain, K ^a   Bommireddy, R ^a   Klezl, Z ^a,c   Williams, J ^a,b  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Lean muscle mass; Metastatic spinal cord compression; Sarcopenia

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PSOAS MUSCLE; SKELETAL MUSCLE; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; SPINAL CORD METASTASIS; SURGICAL MORTALITY; SURVIVAL; THIRD LUMBAR VERTEBRA; COMPLICATION; DECOMPRESSION SURGERY; DIAGNOSTIC IMAGING; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROCEDURES; SARCOPENIA; SECONDARY; SPINAL CORD NEOPLASMS; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; DECOMPRESSION, SURGICAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; SARCOPENIA; SPINAL CORD COMPRESSION; SPINAL CORD NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84957842934     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-015-4050-7     Document Type: Article

References (37)

1. Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643–648
2. Tokuhashi Y, Matsuzaki H, Toriyama S et al (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 15:1110–1113
3. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30(19):2186–2191
4. Tomita K, Kawahara N, Kobayashi T et al (2001) Surgical strategy for spinal metastases. Spine 26:298–306
5. Fourney DR, Frangou EM, Ryken TC et al (2011) Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 29(22):3072–3077
6. Gakhar H, Swamy GN, Bommireddy R et al (2012) A study investigating the validity of modified Tokuhashi score to decide surgical intervention in patients with metastatic spinal cancer. Eur Spine J 22:565
7. Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC et al (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918–1922
8. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635
9. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15:6973–6979
10. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C et al (2010) Sarcopenia and mortality after liver transplantation. J Am Coll Surg 211:271–278
11. Balentine CJ, Enriquez J, FisherW Hodges S, Bansal V, Sansgiry S et al (2010) Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14:1832–1837
12. Baracos Vickie E et al (2010) Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 91(suppl):1133S–1137S
13. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763
14. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889–896
15. Pichard C, Kyle UG, Morabia A et al (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79:613–618
16. Cosqueric G, Sebag A, Ducolombier C et al (2006) Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895–901
17. Metter EJ, Talbot LA, Schrager M, Conwit R (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57:B359–B365
18. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS (2001) Sarcopenia. J Lab Clin Med 137:231–243
19. Roubenoff R (2008) Excess baggage: sarcopenia, obesity, and cancer outcomes. Lancet Oncol 9:605–607
20. Roubenoff R (2002) Exercise, sarcopenia, cognition, and mood. Nestle Nutr Workshop Ser Clin Perform Programme 6:151–159 (discussion 160–152)
21. Roubenoff R (2003) Sarcopenia: effects on body composition and function. J Gerontol A Biol Sci Med Sci 58:1012–1017
22. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M et al (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920–2926
23. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635
24. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15:6973–6979
25. Bouchard DR, Dionne IJ, Brochu M (2009) Sarcopenic/obesity and physical capacity in older men and women: data from the Nutrition as a determinant of successful aging (NuAge)-the Quebec longitudinal study. Obesity (Silver Spring) 17:2082–2088
26. Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I et al (2009) Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr 89:1895–1900
27. Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R (2012) Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One 7(1):e29330. doi:10.1371/journal.pone.0029330
28. Heymsfield SB, Wang Z, Baumgartner RN, Ross R (1997) Human body composition: advances in models and methods. Annu Rev Nutr 17:527–558
29. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R (1998) Cadaver validation of skeletal muscle measurement bymagnetic resonance imaging and computerized tomography. J ApplPhysiol 85:115–122
30. Shen W, Punyanitya M, Wang Z et al (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal crosssectional image. J ApplPhysiol 97:2333–2338
31. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J (1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351:871–875
32. Mourtzakis M, Prado CMM, Lieffers JR et al (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997–1006
33. Lieffers JR, Mourtzakis M, Hall KD et al (2009) A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 89:1173–1179
34. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635
35. Prado CM, Baracos VE, McCargar LJ et al (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264–3268
36. Prado CM, Baracos VE, McCargar LJ et al (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920–2926
37. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M (2012) Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 3:260